The evolving use of measurable residual disease in chronic lymphocytic leukemia clinical trials
Fisher, A, Goradia, H, Martinez-Calle, N, Patten, Pem, Munir, T
Published in Frontiers in oncology (22.02.2023)
Published in Frontiers in oncology (22.02.2023)
Get full text
Journal Article
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
Ioannou, Nikolaos, Hagner, Patrick R., Stokes, Matt, Gandhi, Anita K., Apollonio, Benedetta, Fanous, Mariam, Papazoglou, Despoina, Sutton, Lesley-Ann, Rosenquist, Richard, Amini, Rose-Marie, Chiu, Hsiling, Lopez-Girona, Antonia, Janardhanan, Preethi, Awan, Farrukh T., Jones, Jeffrey, Kay, Neil E., Shanafelt, Tait D., Tallman, Martin S., Stamatopoulos, Kostas, Patten, Piers E.M., Vardi, Anna, Ramsay, Alan G.
Published in Blood (14.01.2021)
Published in Blood (14.01.2021)
Get full text
Journal Article
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease
Bagnara, Davide, Kaufman, Matthew S., Calissano, Carlo, Marsilio, Sonia, Patten, Piers E.M., Simone, Rita, Chum, Philip, Yan, Xiao-Jie, Allen, Steven L., Kolitz, Jonathan E., Baskar, Sivasubramanian, Rader, Christoph, Mellstedt, Hakan, Rabbani, Hodjattallah, Lee, Annette, Gregersen, Peter K., Rai, Kanti R., Chiorazzi, Nicholas
Published in Blood (19.05.2011)
Published in Blood (19.05.2011)
Get full text
Journal Article